speb/financial-data huggingface dataset:
PETS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 6500000.00
PETS income_statement (quarterly, 2025-06-30) — Other Gand A: 12948000.00
PETS income_statement (quarterly, 2025-06-30) — Other Income Expense: -27071000.00
PETS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 6956000.00
PETS balance_sheet (quarterly, 2025-06-30) — Other Investments: 5300000.00
PETS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 187000.00
PETS balance_sheet (quarterly, 2025-06-30) — Other Properties: 29690000.00
PETS balance_sheet (quarterly, 2025-06-30) — Payables: 45139000.00
PETS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 56039000.00
PETS balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 3000.00
PETS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 9000.00
PETS balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 9000.00
PETS balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 299000.00
PETS income_statement (quarterly, 2025-06-30) — Pretax Income: -34143000.00
PETS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1292000.00
PETS balance_sheet (quarterly, 2025-06-30) — Receivables: 1605000.00
PETS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 36777000.00
PETS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2283000.00
PETS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 32393000.00
PETS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 6046000.00
PETS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 18994000.00
PETS balance_sheet (quarterly, 2025-06-30) — Share Issued: 20835210.00
PETS income_statement (quarterly, 2025-06-30) — Special Income Charges: -27258000.00
PETS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 591000.00
PETS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 51546000.00
PETS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 44581000.00
PETS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -5724180.00
PETS income_statement (quarterly, 2025-06-30) — Tax Provision: 9000.00
PETS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
PETS balance_sheet (quarterly, 2025-06-30) — Total Assets: 109839000.00
PETS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 51546000.00
PETS balance_sheet (quarterly, 2025-06-30) — Total Debt: 883000.00
PETS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 51546000.00
PETS income_statement (quarterly, 2025-06-30) — Total Expenses: 58054000.00
PETS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 58293000.00
PETS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 41946000.00
PETS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 677000.00
PETS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -34132000.00
PETS income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 198000.00
PETS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 25098000.00
PETS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -27258000.00
PETS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -27258000.00
PETS balance_sheet (quarterly, 2025-06-30) — Working Capital: 10276000.00
PETS income_statement (quarterly, 2025-09-30) — +Operating Expense: 20795000.00
PETS income_statement (quarterly, 2025-09-30) — +Total Revenue: 44364000.00
PETS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 19119000.00
PETS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1965000.00
PETS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 19161000.00
PETS balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -32000.00
PETS cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 12000.00
PETS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 20889124.00
PETS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.41
PETS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 41127000.00
PETS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2624000.00
PETS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 768000.00
PETS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 30000.00
PETS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 36098000.00
PETS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 36098000.00
PETS cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -22000.00
PETS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -231000.00
PETS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2624000.00
PETS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2174000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -922000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1264000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 185000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Inventory: 3593000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 113000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -115000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -113000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Payable: -737000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 527000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 175000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Receivables: -372000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 185000.00
PETS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 3808000.00
PETS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -372000.00
PETS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -5029000.00
PETS balance_sheet (quarterly, 2025-09-30) — Common Stock: 21000.00
PETS cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -22000.00
PETS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 43055000.00
PETS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 31949000.00
PETS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 10809000.00
PETS balance_sheet (quarterly, 2025-09-30) — Current Assets: 59455000.00
PETS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 477000.00
PETS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 477000.00
PETS balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 995000.00
PETS balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 995000.00
PETS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 56683000.00
PETS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 0.00
PETS cash_flow (quarterly, 2025-09-30) — Deferred Tax: 0.00
PETS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2278000.00
PETS income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 2278000.00
PETS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2278000.00
PETS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 2278000.00
PETS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 20889124.00
PETS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.41
PETS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -8520000.00
PETS income_statement (quarterly, 2025-09-30) — EBIT: -8380000.00
PETS income_statement (quarterly, 2025-09-30) — EBITDA: -6102000.00
PETS cash_flow (quarterly, 2025-09-30) — End Cash Position: 36098000.00
PETS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -231000.00
PETS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -4798000.00
PETS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 14176000.00
PETS balance_sheet (quarterly, 2025-09-30) — Goodwill: 0.00
PETS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 6467000.00
PETS balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 1997000.00
PETS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 29079000.00
PETS income_statement (quarterly, 2025-09-30) — Gross Profit: 12415000.00
PETS income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
PETS balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 0.00
PETS balance_sheet (quarterly, 2025-09-30) — Inventory: 14768000.00
PETS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 43055000.00
PETS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2624000.00
PETS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 5300000.00
PETS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 291000.00
PETS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 291000.00
PETS income_statement (quarterly, 2025-09-30) — Net Income: -8520000.00
PETS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -8520000.00
PETS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -8520000.00
PETS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -8520000.00
PETS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -8520000.00
PETS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -8520000.00
PETS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -8520000.00
PETS income_statement (quarterly, 2025-09-30) — Net Interest Income: -326000.00
PETS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -326000.00
PETS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -209000.00
PETS balance_sheet (quarterly, 2025-09-30) — Net PPE: 29079000.00
PETS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2624000.00
PETS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 36597000.00
PETS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 263000.00
PETS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 263000.00
PETS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -6102000.00
PETS income_statement (quarterly, 2025-09-30) — Normalized Income: -8520000.00
PETS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2174000.00
PETS income_statement (quarterly, 2025-09-30) — Operating Income: -8380000.00
PETS income_statement (quarterly, 2025-09-30) — Operating Revenue: 44364000.00
PETS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 21015559.00
PETS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 6361000.00
PETS income_statement (quarterly, 2025-09-30) — Other Gand A: 14176000.00
PETS income_statement (quarterly, 2025-09-30) — Other Income Expense: 195000.00
PETS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 6467000.00
PETS balance_sheet (quarterly, 2025-09-30) — Other Investments: 5300000.00
PETS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 195000.00
PETS balance_sheet (quarterly, 2025-09-30) — Other Properties: 29079000.00
PETS balance_sheet (quarterly, 2025-09-30) — Payables: 44402000.00
PETS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 55211000.00
PETS balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 3000.00
PETS balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 9000.00
PETS balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 9000.00
PETS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 263000.00
PETS income_statement (quarterly, 2025-09-30) — Pretax Income: -8511000.00
PETS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2624000.00
PETS balance_sheet (quarterly, 2025-09-30) — Receivables: 1965000.00
PETS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 31949000.00
PETS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2278000.00
PETS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 23873000.00
PETS income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 4341000.00
PETS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 18517000.00
PETS balance_sheet (quarterly, 2025-09-30) — Share Issued: 21015559.00
PETS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
PETS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 248000.00
PETS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 43064000.00
PETS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 36588000.00
PETS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
PETS income_statement (quarterly, 2025-09-30) — Tax Provision: 9000.00
PETS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
PETS balance_sheet (quarterly, 2025-09-30) — Total Assets: 100301000.00
PETS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 43064000.00
PETS balance_sheet (quarterly, 2025-09-30) — Total Debt: 768000.00
PETS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 43064000.00
PETS income_statement (quarterly, 2025-09-30) — Total Expenses: 52744000.00
PETS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 57237000.00
PETS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 40846000.00
PETS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 554000.00
PETS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -8380000.00
PETS income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 326000.00
PETS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 25283000.00
PETS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
PETS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
PETS balance_sheet (quarterly, 2025-09-30) — Working Capital: 2772000.00
PETS income_statement (quarterly, 2025-12-31) — +Operating Expense: 19925000.00
PETS income_statement (quarterly, 2025-12-31) — +Total Revenue: 40660000.00
PETS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 20300000.00
PETS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1559000.00
PETS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 19416000.00
PETS balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -24000.00
PETS cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: -19000.00
PETS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 21008521.00
PETS income_statement (quarterly, 2025-12-31) — Basic EPS: -0.50
PETS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 36098000.00
PETS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 652000.00
PETS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 30000.00
PETS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 26914000.00
PETS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 26914000.00
PETS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -1000.00
PETS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 0.00
PETS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 21000.00
PETS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -9205000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1181000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -3953000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -133000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Inventory: 2562000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 114000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -116000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -163000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Payable: 1048000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -2905000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1203000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Receivables: 425000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -133000.00
PETS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1286000.00
PETS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 425000.00
PETS cash_flow (quarterly, 2025-12-31) — Changes In Cash: -9184000.00
PETS balance_sheet (quarterly, 2025-12-31) — Common Stock: 21000.00
PETS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 32757000.00
PETS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 31204000.00
PETS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 8002000.00
PETS balance_sheet (quarterly, 2025-12-31) — Current Assets: 48506000.00
PETS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 485000.00
PETS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 485000.00
PETS balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 832000.00
PETS balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 832000.00
PETS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 54769000.00
PETS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 0.00
PETS cash_flow (quarterly, 2025-12-31) — Deferred Tax: 0.00
PETS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2399000.00
PETS income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 2399000.00
PETS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2399000.00
PETS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 2399000.00
PETS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 21008521.00
PETS income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.50
PETS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -10553000.00
PETS income_statement (quarterly, 2025-12-31) — EBIT: -10469000.00
PETS income_statement (quarterly, 2025-12-31) — EBITDA: -8070000.00
PETS cash_flow (quarterly, 2025-12-31) — End Cash Position: 26914000.00
PETS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
PETS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -9184000.00
PETS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 12194000.00
PETS balance_sheet (quarterly, 2025-12-31) — Goodwill: 0.00
PETS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 5978000.00
PETS balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 1583000.00
PETS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 28181000.00
PETS income_statement (quarterly, 2025-12-31) — Gross Profit: 9456000.00
PETS income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
PETS cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 8000.00
PETS balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 0.00
PETS balance_sheet (quarterly, 2025-12-31) — Inventory: 12206000.00
PETS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 32757000.00
PETS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 21000.00
PETS balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 5300000.00
PETS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 167000.00
PETS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 167000.00
PETS income_statement (quarterly, 2025-12-31) — Net Income: -10553000.00
PETS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -10553000.00
PETS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -10553000.00
PETS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -10553000.00
PETS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -10553000.00
PETS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -10553000.00
PETS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -10553000.00
PETS income_statement (quarterly, 2025-12-31) — Net Interest Income: -221000.00
PETS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -221000.00
PETS cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 1000.00
PETS balance_sheet (quarterly, 2025-12-31) — Net PPE: 28181000.00
PETS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 21000.00
PETS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 26788000.00
PETS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 263000.00
PETS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 263000.00
PETS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -8070000.00
PETS income_statement (quarterly, 2025-12-31) — Normalized Income: -10553000.00
PETS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -9205000.00
PETS income_statement (quarterly, 2025-12-31) — Operating Income: -10469000.00
PETS income_statement (quarterly, 2025-12-31) — Operating Revenue: 40660000.00
PETS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 21382521.00
PETS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 7569000.00
PETS income_statement (quarterly, 2025-12-31) — Other Gand A: 12194000.00
PETS income_statement (quarterly, 2025-12-31) — Other Income Expense: 148000.00
PETS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 5978000.00
PETS balance_sheet (quarterly, 2025-12-31) — Other Investments: 5300000.00
PETS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 148000.00
PETS balance_sheet (quarterly, 2025-12-31) — Other Properties: 28181000.00
PETS balance_sheet (quarterly, 2025-12-31) — Payables: 45450000.00
PETS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 53452000.00
PETS balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 3000.00
PETS balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 9000.00
PETS balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 9000.00
PETS balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 258000.00
PETS income_statement (quarterly, 2025-12-31) — Pretax Income: -10542000.00
PETS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 21000.00
PETS balance_sheet (quarterly, 2025-12-31) — Receivables: 1559000.00
PETS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 31204000.00
PETS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2399000.00
PETS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 13320000.00
PETS income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 5332000.00
PETS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 17526000.00
PETS balance_sheet (quarterly, 2025-12-31) — Share Issued: 21382521.00
PETS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
PETS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 254000.00
PETS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 32766000.00
PETS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 26779000.00
PETS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PETS income_statement (quarterly, 2025-12-31) — Tax Provision: 11000.00
PETS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
PETS balance_sheet (quarterly, 2025-12-31) — Total Assets: 87965000.00
PETS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 32766000.00
PETS balance_sheet (quarterly, 2025-12-31) — Total Debt: 652000.00
PETS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 32766000.00
PETS income_statement (quarterly, 2025-12-31) — Total Expenses: 51129000.00
PETS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 55199000.00
PETS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 39459000.00
PETS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 430000.00
PETS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -10469000.00
PETS income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 221000.00
PETS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 25150000.00
PETS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
PETS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PETS balance_sheet (quarterly, 2025-12-31) — Working Capital: -6263000.00
PETS income_statement (annual, 2026-03-31) — +Operating Expense: 81631000.00
PETS income_statement (quarterly, 2026-03-31) — +Operating Expense: 19634000.00
PETS income_statement (annual, 2026-03-31) — +Total Revenue: 179021000.00
PETS income_statement (quarterly, 2026-03-31) — +Total Revenue: 42817000.00
PETS balance_sheet (annual, 2026-03-31) — Accounts Payable: 20906000.00
PETS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 20906000.00
PETS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1908000.00
PETS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1908000.00
PETS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -31912000.00
PETS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -31912000.00
PETS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 19647000.00
PETS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 19647000.00
PETS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -25000.00
PETS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -25000.00
PETS cash_flow (annual, 2026-03-31) — Asset Impairment Charge: 29348000.00
PETS cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 2103000.00
PETS income_statement (annual, 2026-03-31) — Basic Average Shares: 20921361.00
PETS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 21033007.00
PETS income_statement (annual, 2026-03-31) — Basic EPS: -2.74
PETS income_statement (quarterly, 2026-03-31) — Basic EPS: -0.19
PETS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 54720000.00
PETS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 26914000.00
PETS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 19510000.00
PETS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 19510000.00
PETS cash_flow (annual, 2026-03-31) — Capital Expenditure: -4615000.00
PETS cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -720000.00
PETS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 535000.00
PETS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 535000.00
PETS balance_sheet (annual, 2026-03-31) — Capital Stock: 30000.00
PETS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 30000.00
PETS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 21412000.00
PETS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 21412000.00
PETS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 21412000.00
PETS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 21412000.00
PETS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -21000.00
PETS cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 3000.00
PETS cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: -299000.00
PETS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -38000.00
PETS cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -4615000.00
PETS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -720000.00
PETS cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: -28394000.00
PETS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4744000.00
PETS cash_flow (annual, 2026-03-31) — Change In Account Payable: -2658000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 606000.00
PETS cash_flow (annual, 2026-03-31) — Change In Accrued Expense: -4302000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -326000.00
PETS cash_flow (annual, 2026-03-31) — Change In Income Tax Payable: 62000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: -141000.00
PETS cash_flow (annual, 2026-03-31) — Change In Inventory: 471000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Inventory: -3528000.00
PETS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 454000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 115000.00
PETS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -461000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -117000.00
PETS cash_flow (annual, 2026-03-31) — Change In Other Working Capital: -1396000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -143000.00
PETS cash_flow (annual, 2026-03-31) — Change In Payable: -2596000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Payable: 465000.00
PETS cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: -6898000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 139000.00
PETS cash_flow (annual, 2026-03-31) — Change In Prepaid Assets: -1007000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 1191000.00
PETS cash_flow (annual, 2026-03-31) — Change In Receivables: 445000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Receivables: -326000.00
PETS cash_flow (annual, 2026-03-31) — Change In Tax Payable: 62000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: -141000.00
PETS cash_flow (annual, 2026-03-31) — Change In Working Capital: -8392000.00
PETS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2669000.00
PETS cash_flow (annual, 2026-03-31) — Changes In Account Receivables: 445000.00
PETS cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -326000.00
PETS cash_flow (annual, 2026-03-31) — Changes In Cash: -33308000.00
PETS cash_flow (quarterly, 2026-03-31) — Changes In Cash: -5502000.00
PETS balance_sheet (annual, 2026-03-31) — Common Stock: 21000.00
PETS balance_sheet (quarterly, 2026-03-31) — Common Stock: 21000.00
PETS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 28931000.00
PETS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 28931000.00
PETS income_statement (annual, 2026-03-31) — Cost Of Revenue: 128805000.00
PETS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 28875000.00
PETS balance_sheet (annual, 2026-03-31) — Current Accrued Expenses: 7447000.00
PETS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 7447000.00
PETS balance_sheet (annual, 2026-03-31) — Current Assets: 43564000.00
PETS balance_sheet (quarterly, 2026-03-31) — Current Assets: 43564000.00
PETS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 493000.00
PETS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 493000.00
PETS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 493000.00
PETS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 493000.00
PETS balance_sheet (annual, 2026-03-31) — Current Deferred Liabilities: 689000.00
PETS balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 689000.00
PETS balance_sheet (annual, 2026-03-31) — Current Deferred Revenue: 689000.00
PETS balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 689000.00
PETS balance_sheet (annual, 2026-03-31) — Current Liabilities: 52034000.00
PETS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 52034000.00
PETS cash_flow (annual, 2026-03-31) — Deferred Income Tax: -2816000.00
PETS cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -2816000.00
PETS cash_flow (annual, 2026-03-31) — Deferred Tax: -2816000.00
PETS cash_flow (quarterly, 2026-03-31) — Deferred Tax: -2816000.00
PETS cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 9387000.00
PETS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 2427000.00
PETS income_statement (annual, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 9387000.00
PETS income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 2427000.00
PETS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 9387000.00
PETS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 2427000.00
PETS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 9387000.00
PETS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 2427000.00
PETS income_statement (annual, 2026-03-31) — Diluted Average Shares: 20921361.00
PETS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 21033007.00
PETS income_statement (annual, 2026-03-31) — Diluted EPS: -2.74
PETS income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.19
PETS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -57286000.00
PETS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -4061000.00
PETS balance_sheet (annual, 2026-03-31) — Dividends Payable: 0.00
PETS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 0.00
PETS income_statement (annual, 2026-03-31) — EBIT: -31415000.00
PETS income_statement (quarterly, 2026-03-31) — EBIT: -5692000.00
PETS income_statement (annual, 2026-03-31) — EBITDA: -22028000.00
PETS income_statement (quarterly, 2026-03-31) — EBITDA: -3265000.00
PETS cash_flow (annual, 2026-03-31) — End Cash Position: 21412000.00
PETS cash_flow (quarterly, 2026-03-31) — End Cash Position: 21412000.00
PETS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -299000.00
PETS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -38000.00
PETS cash_flow (annual, 2026-03-31) — Free Cash Flow: -33009000.00
PETS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -5464000.00
PETS income_statement (annual, 2026-03-31) — General And Administrative Expense: 50733000.00
PETS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 11415000.00
PETS balance_sheet (annual, 2026-03-31) — Goodwill: 0.00
PETS balance_sheet (quarterly, 2026-03-31) — Goodwill: 0.00
PETS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 5489000.00
PETS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 5489000.00
PETS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 1933000.00
PETS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1933000.00
PETS balance_sheet (annual, 2026-03-31) — Gross PPE: 58750000.00
PETS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 58750000.00
PETS income_statement (annual, 2026-03-31) — Gross Profit: 50216000.00
PETS income_statement (quarterly, 2026-03-31) — Gross Profit: 13942000.00
PETS cash_flow (annual, 2026-03-31) — Income Tax Paid Supplemental Data: 52000.00
PETS cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: -22000.00
PETS balance_sheet (annual, 2026-03-31) — Income Tax Payable: 20000.00
PETS balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 20000.00
PETS balance_sheet (annual, 2026-03-31) — Inventory: 13608000.00
PETS balance_sheet (quarterly, 2026-03-31) — Inventory: 13608000.00
PETS balance_sheet (annual, 2026-03-31) — Invested Capital: 28931000.00
PETS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 28931000.00
PETS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -4615000.00
PETS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -720000.00
PETS balance_sheet (annual, 2026-03-31) — Investments And Advances: 5300000.00
PETS balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 5300000.00
PETS balance_sheet (annual, 2026-03-31) — Land And Improvements: 3700000.00
PETS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 3700000.00
PETS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 42000.00
PETS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 42000.00
PETS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 42000.00
PETS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 42000.00
PETS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 35028000.00
PETS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 35028000.00
PETS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 0.00
PETS income_statement (annual, 2026-03-31) — Net Income: -57286000.00
PETS income_statement (quarterly, 2026-03-31) — Net Income: -4061000.00
PETS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -57286000.00
PETS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -4061000.00
PETS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -57286000.00
PETS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -4061000.00
PETS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -57286000.00
PETS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4061000.00
PETS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -57286000.00
PETS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4061000.00
PETS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -57286000.00
PETS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -4061000.00
PETS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -57286000.00
PETS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -4061000.00
PETS income_statement (annual, 2026-03-31) — Net Interest Income: 511000.00
PETS income_statement (quarterly, 2026-03-31) — Net Interest Income: 1256000.00
PETS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 511000.00
PETS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1256000.00
PETS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -278000.00
PETS cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -41000.00
PETS balance_sheet (annual, 2026-03-31) — Net PPE: 26838000.00
PETS balance_sheet (quarterly, 2026-03-31) — Net PPE: 26838000.00
PETS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -4615000.00
PETS cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -720000.00
PETS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 23451000.00
PETS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 23451000.00
PETS balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 175000.00
PETS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 175000.00
PETS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 175000.00
PETS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 175000.00
PETS income_statement (annual, 2026-03-31) — Normalized EBITDA: 5230000.00
PETS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -3265000.00
PETS income_statement (annual, 2026-03-31) — Normalized Income: -30063435.40
PETS income_statement (quarterly, 2026-03-31) — Normalized Income: -4061000.00
PETS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -28394000.00
PETS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -4744000.00
PETS income_statement (annual, 2026-03-31) — Operating Income: -31415000.00
PETS income_statement (quarterly, 2026-03-31) — Operating Income: -5692000.00
PETS income_statement (annual, 2026-03-31) — Operating Revenue: 179021000.00
PETS income_statement (quarterly, 2026-03-31) — Operating Revenue: 42817000.00
PETS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 21385638.00
PETS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 21385638.00
PETS balance_sheet (annual, 2026-03-31) — Other Current Assets: 6378000.00
PETS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 6378000.00
PETS income_statement (annual, 2026-03-31) — Other Gand A: 50733000.00
PETS income_statement (quarterly, 2026-03-31) — Other Gand A: 11415000.00
PETS income_statement (annual, 2026-03-31) — Other Income Expense: -26455000.00
PETS income_statement (quarterly, 2026-03-31) — Other Income Expense: 273000.00
PETS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 5489000.00
PETS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 5489000.00
PETS balance_sheet (annual, 2026-03-31) — Other Inventories: 13608000.00
PETS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 13608000.00
PETS balance_sheet (annual, 2026-03-31) — Other Investments: 5300000.00
PETS balance_sheet (quarterly, 2026-03-31) — Other Investments: 5300000.00
PETS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 803000.00
PETS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 273000.00
PETS balance_sheet (annual, 2026-03-31) — Other Properties: 512000.00
PETS balance_sheet (quarterly, 2026-03-31) — Other Properties: 512000.00
PETS balance_sheet (annual, 2026-03-31) — Payables: 43405000.00
PETS balance_sheet (quarterly, 2026-03-31) — Payables: 43405000.00
PETS balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 50852000.00
PETS balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 50852000.00
PETS balance_sheet (annual, 2026-03-31) — Preferred Shares Number: 3000.00
PETS balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 3000.00
PETS balance_sheet (annual, 2026-03-31) — Preferred Stock: 9000.00
PETS balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 9000.00
PETS balance_sheet (annual, 2026-03-31) — Preferred Stock Equity: 9000.00
PETS balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 9000.00
PETS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 258000.00
PETS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 258000.00
PETS income_statement (annual, 2026-03-31) — Pretax Income: -57359000.00
PETS income_statement (quarterly, 2026-03-31) — Pretax Income: -4163000.00
PETS balance_sheet (annual, 2026-03-31) — Properties: 0.00
PETS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
PETS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
PETS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -4615000.00
PETS cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -720000.00
PETS balance_sheet (annual, 2026-03-31) — Receivables: 1908000.00
PETS balance_sheet (quarterly, 2026-03-31) — Receivables: 1908000.00
PETS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 128805000.00
PETS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 28875000.00
PETS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 9387000.00
PETS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 2427000.00
PETS balance_sheet (annual, 2026-03-31) — Retained Earnings: 9263000.00
PETS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 9263000.00
PETS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 21511000.00
PETS income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 5792000.00
PETS income_statement (annual, 2026-03-31) — Selling General And Administration: 72244000.00
PETS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 17207000.00
PETS balance_sheet (annual, 2026-03-31) — Share Issued: 21385638.00
PETS balance_sheet (quarterly, 2026-03-31) — Share Issued: 21385638.00
PETS income_statement (annual, 2026-03-31) — Special Income Charges: -27258000.00
PETS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
PETS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 1365000.00
PETS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 272000.00
PETS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 28940000.00
PETS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 28940000.00
PETS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 23442000.00
PETS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 23442000.00
PETS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -35435.40
PETS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
PETS income_statement (annual, 2026-03-31) — Tax Provision: -73000.00
PETS income_statement (quarterly, 2026-03-31) — Tax Provision: -102000.00
PETS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.00
PETS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.02
PETS balance_sheet (annual, 2026-03-31) — Total Assets: 81191000.00
PETS balance_sheet (quarterly, 2026-03-31) — Total Assets: 81191000.00
PETS balance_sheet (annual, 2026-03-31) — Total Capitalization: 28940000.00
PETS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 28940000.00
PETS balance_sheet (annual, 2026-03-31) — Total Debt: 535000.00
PETS balance_sheet (quarterly, 2026-03-31) — Total Debt: 535000.00
PETS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 28940000.00
PETS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 28940000.00
PETS income_statement (annual, 2026-03-31) — Total Expenses: 210436000.00
PETS income_statement (quarterly, 2026-03-31) — Total Expenses: 48509000.00
PETS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 52251000.00
PETS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 52251000.00
PETS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 37627000.00
PETS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 37627000.00
PETS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 217000.00
PETS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 217000.00
PETS income_statement (annual, 2026-03-31) — Total Operating Income As Reported: -58673000.00
PETS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -5692000.00
PETS income_statement (annual, 2026-03-31) — Total Other Finance Cost: -511000.00
PETS income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -1256000.00
PETS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 22499000.00
PETS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 22499000.00
PETS income_statement (annual, 2026-03-31) — Total Unusual Items: -27258000.00
PETS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
PETS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -27258000.00
PETS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
PETS balance_sheet (annual, 2026-03-31) — Working Capital: -8470000.00
PETS balance_sheet (quarterly, 2026-03-31) — Working Capital: -8470000.00
PETS.L income_statement (annual, 2022-03-31) — +Operating Expense: 503400000.00
PETS.L income_statement (annual, 2022-03-31) — +Total Revenue: 1317800000.00
PETS.L balance_sheet (annual, 2022-03-31) — Accounts Payable: 118500000.00